CD8A and cancer: In addition, YTHDF2 expression was associated with CD8+ T cell levels in 12 cancer types, CD4+T cell levels in 14 cancer types, macrophage levels in 14 cancer types, neutrophil levels in 12 cancer types, and DC levels in 12 cancer types (Supplementary Table 5).